Regulating genetically modified food: Policy trajectories, political culture, and risk perceptions in the U.S., Canada, and EU

Politics and the Life Sciences

Volumn 29, Issue 2, 2010, Pages 17-39

  Wohlers, Anton E ^a  

^a CAMERON UNIVERSITY   (United States)

Author keywords

Biotechnology policy; genetic engineering in agriculture; genetically modified food; political culture; risk perceptions

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CANADA; CULTURAL ANTHROPOLOGY; DECISION MAKING; ETHICS; GENETIC ENGINEERING; GENETICALLY MODIFIED FOOD; HEALTH; HUMAN; LEGAL ASPECT; PERCEPTION; POLICY; POLITICS; PUBLIC OPINION; RISK; UNCERTAINTY; UNITED STATES;

BIOTECHNOLOGY; CANADA; CULTURE; DECISION MAKING; FOOD, GENETICALLY MODIFIED; GENETIC ENGINEERING; HUMANS; PERCEPTION; POLITICS; PUBLIC OPINION; PUBLIC POLICY; RISK; UNCERTAINTY; UNITED STATES; WORLD HEALTH;

EID: 79960732796     PISSN: 07309384     EISSN: None     Source Type: Journal    
DOI: 10.2990/29_2_17     Document Type: Article

References (202)

1. Michael J. Reiss and Roger Straughan, Improving Nature? The Science and Ethics of Genetic Engineering (Cambridge: Cambridge University Press, 1996).
2. William A. Munro and Rachel A. Schurman, "Sustaining outrage: Cultural capital, strategic location, and motivating sensibilities in the U.S. anti-genetic engineering movement," in The Fight Over Food. Producers, Consumers, and Activists Challenge the Global Food System, ed. Winne Wright and Gerad Middendorf (University Park: Pennsylvania State University Press, 2008), pp. 145-176.
3. Sheila Jasanoff, "Product, process, or programme: Three cultures and the regulation of biotechnology," in Resistance to New Technology. Nuclear Power, Information Technology and Biotechnology, ed. Martin Bauer (Cambridge: Cambridge University Press, 1995), pp. 311-331.
4. Claire Dunlop, "GMOs and regulatory styles." Environmental Politics, 2000, 9(2):149-155.
5. George Gaskell, "Troubled waters: The Atlantic divide on biotechnology policy," in Biotechnology 1996-2000: The Years of Controversy, ed. George Gaskell and Martin Bauer (London: NMSI Trading Ltd, 2001), pp. 96-115.
6. Grant E. Isaac, Agricultural Biotechnology and Transatlantic Trade: Regulatory Barriers to GM Crops (New York: CABI Publishing, 2002).
7. Philip Katz, Penny Macdonald, and Gordon Mackanzie, "The evolving GMO food trade policy debate: Towards a global regulatory regime?" in The Regulation of Agricultural Biotechnology, ed. Robert E. Evenson and Vittorio Santaniello (Cambridge: CABI Publishing, 2004), pp. 25-34.
8. Gregory Jaffe, "Regulating transgenic crops: A comparative analysis of different regulatory processes," Transgenic Research, 2004, 13(1):5-19. (Pubitemid 38335385)
9. Jean-Paul Gaudillière, "Globalization and regulation in the biotech world: The transatlantic debates over cancer genes and genetically modified crops," OSIRIS, 2006, 21:251-272. (Pubitemid 44363270)
10. Adam D. Sheingate, "Promotion versus precaution: The evolution of biotechnology policy in the United States," British Journal of Political Science, 2006, 36(2):243-268. (Pubitemid 43383285)
11. Geert Hofstede, Culturés Consequences: International Differences in Work-Related Values (Beverly Hills: Sage, 1980).
12. Howard Margolis, Dealing with Risk: Why the Public and Experts Disagree on Environmental Issues (Chicago: University of Chicago Press, 1996).
13. Robin M. Williams, American Society (New York: Knopf Williams, 1974).
14. Daniel J. Elazar, American Federalism: A View from the States (New York: Harper & Row, 1984).
15. Gabriel A. Almond and Sidney Verba, The Civic Culture: Political Attitudes and Democracy in Five Nations (Princeton: Princeton University Press, 1963).
16. Karl W. Deutsch, Politics and Government (Boston: Houghton Mifflin, 1970).
17. Brendon Swedlow, "Toward cultural analysis in policy analysis: Picking up where Aaron Wildavsky left off," Journal of Comparative Policy Analysis, 2002, 4(3):267-285.
18. Robert Hoppe, "Cultures of public policy problems," Journal of Comparative Policy Analysis, 2002, 4(3):305-326.
19. Charles H. Turner and Alfons Trompenaars, The Seven Cultures of Capitalism: Value Systems for Creating Wealth in the United States, Japan, Germany, France, Britain, Sweden, and the Netherlands (New York: Doubleday Business, 1993).
20. H. Kevin Steensma, Louis Marino, K. Mark Weaver, and Pat H. Dickson, "The influence of national culture on the formation of technology alliances by entrepreneurial firms," The Academy of Management Journal, 2000, 43(5):951-973.
21. Geert Hofstede, Cultures and Organizations: Software of the Mind (New York: McGraw-Hill, 1997).
22. Geert Hofstede and Gert Jan Hofstede, Culture and Organizations: Software of the Mind. Intercultural Cooperation and Its Importance for Survival (New York: McGraw-Hill, 2005).
23. Hofstede and Hofstede.
24. Sengun Yniyurt and Janell Townsend. "Does culture explain acceptance of new products in a country? An empirical investigation." International Marketing Review, 2003, 20(4):377-397.
25. Hofstede and Hofstede, p. 190.
26. William D. Rowe, "Risk analysis: A tool for policy decisions," in Risk and Society: The Interaction of Science and Public Policy, ed. Marvin Waterstone (Boston: Kluwer Academic Publishers, 1992).
27. Odelia Funke, "Biopolitics and public policy: Controlling biotechnology." PS: Political Science and Politics, 1985, 18(1):69-77.
28. Peter M. Senge, The Fifth Discipline: The Art and Practice of the Learning Organization (New York: Doubleday, 1990).
29. George A. Kelly, The Psychology of Personal Constructs (New York: Norton and Sons, 1955).
30. Colin Eden and Jim Radford, Tackling Strategic Problems (Newbury Park: Sage, 1990).
31. Fay Fransella and Don Bannister, A Manual for Repertory Grid Technique (London: Academic Press, 1977).
32. Lennart Sjöberg, "Principles of risk perception applied to gene technology: To overcome the resistance to applications of biotechnology, research on risk perception must take a closer look at the publićs reasons for rejecting this technology." European Molecular Biology Organization, 2004, 5:S47-S51.
33. Margolis, p. 76.
34. Paul Slovic, Baruch Fischoff, and Sarah Lichtenstein, "Facts and fears: Understanding perceived risk," in Societal Risk Assessment: How Safe is Safe Enough? ed. Richard Schwing and Walter Albers (New York: Plenum Press, 1976), pp. 181-214.
35. Richard Nisbett and Lee Ross, Human Inference: Strategies and Shortcomings of Social Judgment (Englewood Cliffs: Prentice-Hall, 1980).
36. Amos Tversky and Daniel Kahneman "Rational choice and the framing of decision," Journal of Business, 1986, 59:251-278.
37. Paul Slovic, "Perception of risk: Reflections on the psychometric paradigm," in Social Theories of Risk, ed. Sheldon Krimsky and Dominic Golding (New York: Praeger, 1992), pp. 117-152.
38. Margolis.
39. Brian Wynne, "Creating pubic alienation: Expert cultures of risk and ethics on GMOs," Science as Culture, 2001, 10(4):445-481.
40. Sjöberg, p. S48.
41. Margolis, p. 76.
42. Margolis, pp. 75-78.
43. James E. Anderson, Public Policymaking (Boston: Houghton Mifflin, 1990), p. 5.
44. Roger W. Cobb and Charles Elder, Participation in American Politics (Boston: Allyn and Bacon, 1972).
45. Randall B. Ripley and Grace A. Franklin, Policy Implementation and Bureaucracy (Chicago: Dorsey Press, 1986).
46. Michael Lipsky, Street Level Bureaucracy: Dilemmas of the Individual in Public Services (New York: Russel Sage Foundation, 1980).
47. Peter M. Senge et al., The Fifth Discipline Handbook: Strategies and Tools for Building a Learning Organization (New York: Doubleday, 1994).
48. Hofstede and Hofstede.
49. The Mellman Group, "Memorandum to the Pew Initiative on Food and Biotechnology, Re: Review of Public Opinion Research" (Washington, DC: Pew Charitable Trusts, 2006), http://www.pewtrusts.org/news-room-detail.aspx?id= 32802
50. William K. Hallman et al., Americans and GM Foods: Knowledge, Opinion, and Interest in 2004 (New Brunswick, NJ: Rutgers Food Policy Institute, 2004).
51. Thomas J. Hoban, Public Attitudes Towards Agricultural Biotechnology, ESA Working Paper No. 04-09 (New York: Agricultural and Development Economics Division, Food and Agricultural Organization of the United Nations, 2004).
52. Thomas J. Hoban, American Consumerś Awareness and Acceptance of Biotechnology (Washington, DC: National Agricultural Biotechnology Council, 2002).
53. Thomas J. Hoban, "Consumer acceptance of biotechnology in the United States and Japan," Food Technology, 1999, 53:85-88.
54. Thomas J. Hoban, "Public perceptions and understanding of agricultural biotechnology," Economic Perspectives: An Electronic Journal of the Department of State 4 (1999), http://usinfo.state.gov/journals/ites/1099/ ijee/ bio-hoban.htm (accessed October 14, 2006).
55. Thomas J. Hoban, "Consumer acceptance of biotechnology: An international perspective," Nature Biotechnology, 1997, 15:232-234. (Pubitemid 27118265)
56. Thomas J. Hoban, "Trends in consumer acceptance and awareness of biotechnology," Journal of Food Distribution Research, 1996, 27(1):1-10.
57. Thomas J. Hoban, Agricultural Biotechnology: Public Attitudes and Educational Needs (Raleigh, NC: North Carolina State University Press, 1990).
58. Brian J. Schilling, William K. Hallman, Adesoji O. Adelaja, and Lucas J. Marxen, Consumer Knowledge of Food Biotechnology. A Descriptive Study of U.S. Residents (New Brunswick, NJ: Rutgers Food Policy Institute, 2002).
59. Marianne McGarry Wolf and Christine Domegan, "A comparison of consumer attitudes towards GM food in Ireland and the United States: A case study over time," in Market Development for Genetically Modified Foods, ed. Vittorio Santaniollo, Robert E. Evenson, and David Zilberman (New York: CABI Publishing, 2002), pp. 25-38.
60. William K. Hallman and Jennifer Metcalfe, Public Perceptions of Agricultural Biotechnology: A Survey of New Jersey Residents (New Brunswick, NJ: Rutgers Food Policy Institute, 1994).
61. Thomas J. Hoban and Patricia Kendall, Consumer Attitudes About the Use of Biotechnology in Agriculture and Food Production (Raleigh, NC: North Carolina State University Press, 1992).
62. Decima Research, Emerging Technologies Tracking (Ottawa: Decima Research, 2006).
63. Pollara Research, Public Opinion Research into Biotechnology Issues in Canada (Toronto: Pollara Research, 2003).
64. Pollara Research and Earnscliffe Research and Communications, Public Opinion Research into Biotechnology Issues (Ottawa and Toronto: Pollara Research and Earnschliffe Research and Communications, 2000).
65. Edna F. Einsiedel and Jennifer M. Medlock, "Canada on the gene trail," in Biotechnology 1996-2000. The Years of Controversy, ed. George Gaskell and Martin W. Bauer (London: NMSI Trading Ltd., 2001), pp. 145-156.
66. Peter Oosterveeer, Global Governance of Food Production and Consumption. Issues and Challenges (Cheltenham: Edward Elgar Publishing, 2007), p. 120.
67. Food and Drug Administration, "Statement of policy: Foods derived from new plant varieties," 57 Federal Register, 1992: 22984-23005.
68. Hoban, 1990.
69. William B. Lacy, Lawrence Busch, and Laura L. Lacy, "Public perceptions of agricultural biotechnology," in Agricultural Biotechnology: Issues and Choices, ed. Bill R. Baumgardt and Marshall A. Martin (West Lafayette: Purdue University Agricultural Experiment Station, 1991), pp. 139-161.
70. Hoban and Kendall.
71. Hallman and Metcalfe.
72. Thomas J. Hoban, "International acceptance of agricultural biotechnology," in Agricultural Biotechnology and Environmental Quality: Gene Escape and Pest Resistance, ed. Ralph W. F. Hardy and Jane B. Segelken (Ithaca, NY: National Agricultural Biotechnology Council Report, 1998), p. 61.
73. Jennifer Ferrara, "Paving the way for biotechnology: Federal regulations and industry PR," in Redesigning Life? The Worldwide Challenges to Genetic Engineering, ed. Brian Tokar (London: Zed Books Ltd., 2001), pp. 297- 305.
74. Dave Toke, The Politics of GM Food: A Comparative Study of the UK, USA, and EU (London: Routledge, 2004).
75. Michael Barbee, Politically Incorrect Nutrition: Finding Reality in the Mire of Food Industry Propaganda (Ridgefield: Vital Health Publishing, 2004).
76. John C. Harrington, The Challenge to Power: Money, Investing, and Democracy (White River Junction, VT: Chelsea Green Publishing, 2005).
77. John M. Reilly, "Consumer effects of biotechnology," Agriculture Information Bulletin, December 1989, 581:1-11.
78. Darrell M. West, Biotechnology Policy Across National Boundaries. The Science-Industrial Complex (New York: Palgrave MacMillan, 2007), pp. 51-60.
79. Food and Drug Administration, "Genetically engineered foods: Fears & facts. An interview with FDÁs Jim Maryanski," FDA Consumer, 1993 (January/February).
80. Food and Drug Administration, Completed Consultations on Bioengineered Foods, http://www. accessdata.fda.gov/scripts/fcn/fcnNavigation. cfm?rpt5bioListing (accessed May 1, 2010).
81. Donna V. Vogt, Food Biotechnology in the United States: Science, Regulation, and Issues (Washington, DC: CRS Report for Congress, Domestic Social Policy Division), p. CRS 9, http://www.whprp.org/NLE/CRSreports/science/ st-41.pdf (accessed May 10, 2010).
82. Food and Drug Administration, 1992.
83. Food and Drug Administration, Biotechnology of Food, FDA Backgrounder BG94-4 (Washington DC: Center for Food Safety and Applied Nutrition, May 18, 1994).
84. Food and Drug Administration, "First biotech tomato marketed," FDA Consumer Magazine, 1994 (September):3-4.
85. West, p. 53.
86. Food and Drug Administration, 1994
87. Thomas J. Hoban, American Consumerś Awareness and Acceptance of Biotechnology (Washington, DC: National Agricultural Biotechnology Council, 2002).
88. Thomas J. Hoban, "Consumer acceptance of biotechnology in the United States and Japan," Food Technology, 1999, 53(5):50-53. (Pubitemid 129591077)
89. McGarry Wolf and Domegan.
90. Schilling et al.
91. Hallman et al.
92. Pew Initiative on Food and Biotechnology, p. 3.
93. Hoban, 1990.
94. Hoban, 1997.
95. Hoban, 1999.
96. Hoban, 2002.
97. Linda Zimmerman, Patricia Kendall, Martha Stone, and Thomas Hoban, "Consumer knowledge and concern about biotechnology and food safety," Food Technology, 1994, 48(11):71-77.
98. James Shanahan, Dietram Scheufele, and Eunjung Lee, "The polls-trends: Attitudes about agricultural biotechnology and genetically modified organisms," Public Opinion Quarterly, 2001, 65:267-281.
99. Schilling et al.
100. McGarry, Wolf, and Domegan.
101. Hallman et al.
102. Pew Initiative on Food and Biotechnology, p. 2.
103. MarkWinston, Travels in the Genetically Modified Zone (Cambridge, MA: Harvard University Press, 2002), p. 236.
104. George Gaskell et al., "Biotechnology and the European public," Nature Biotechnology, 2000, 18:935-938. (Pubitemid 32977370)
105. Food and Drug Administration, Safety Assurance of Foods Derived by Modern Biotechnology in the United States (Washington, DC: Center for Food Safety and Applied Nutrition, 1996).
106. Food and Drug Administration, FDÁs Policy for Foods Developed by Biotechnology (Washington DC: Center for Food Safety and Applied Nutrition, 1995).
107. Food and Drug Administration, 1995.
108. Toke, p. 107.
109. Luca Bucchini and Lynn R.Goldman, "Starlink corn: A risk analysis," Environmental Health Perspectives, 2002, 110(1):5-13. (Pubitemid 34110696)
110. Food and Drug Administration, 1996.
111. Statement, James H. Maryanski to the Committee on Agriculture, Nutrition, and Forestry, United States Senate, Subject: Biotechnology Issues, October 7, 1999, http:// agriculture.senate.gov/Hearings/Hearings-1999/mar99107. htm (accessed September 15, 2006).
112. Statement, Joseph A. Levitt to the Health, Education, Labor, and Pensions Committee, United States Senate, Subject: Regulatory Program for Foods Derived from Plants Using the Tools of Modern Biotechnology, September 26, 2000, http://www.biotech-info.net/JAL.html (accessed September 15, 2006).
113. Food and Drug Administration, "Are bioengineered foods safe?" FDA Consumer Magazine, 2000 (January/ February), http://www.agbioworld.org/ biotech-info/articles/ biotech-art/fda-mag.html (accessed September 25, 2006).
114. Department of Health and Human Services, "Premarket notice concerning bioengineering foods (proposed rule)," 66 Federal Register 12 (January 18, 2001): 4706-4738, http://www.fda.gov/Food/ GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/Biotechnology/ ucm096149.htm (accessed November 12, 2009).
115. Food and Drug Administration, "Completed Consultations on Bioengineered Foods."
116. Department of Health and Human Services, 2001.
117. Food and Drug Administration, Talk Paper. FDA Proposes Draft Guidance for Industry for New Plant Varieties Intended for Food Use (Washington, DC: Center for Food Safety and Applied Nutrition, 2004).
118. Food and Drug Administration, Guidance for Industry. Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use (Washington, DC: Food and Drug Administration, Center for Food Safety and Applied Nutrition, 2006).
119. Food and Drug Administration, "Completed Consultations on Bioengineered Foods."
120. Colin A. Carter and Guillaume P. Gruère, "International approval and labeling regulations of genetically modified food in major trading countries," in Regulating Agricultural Biotechnology. Economic and Policy, ed. Richard E. Just, Julian M. Alston, and David Zilberman (New York: Springer Science + Business Media), p. 467.
121. Food and Drug Administration, Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using Bioengineering (Washington DC: Center for Food and Applied Nutrition, 2001).
122. Food and Drug Administration, 2004.
123. Food and Drug Administration, Guidance for Industry: Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals - Draft Guidance (Washington, DC: Food and Drug Administration and Department of Agriculture, 2002).
124. Linda Bren, "Genetic engineering: The future of foods?" FDA Consumer Magazine, 2003 (November- December).
125. Denis J. Murphy, "Improving containment strategies in biopharming," Plant Biotechnology Journal, 2007, 5:555-569. (Pubitemid 47196372)
126. Elisabeth Abergel and Katherine Barrett, "Putting the cart before the horse: A review of biotechnology policy in Canada," Journal of Canadian Studies, 2002, 37(3):135-161.
127. Abergel and Barrett, p. 138
128. Abergel and Barrett, p. 141.
129. Standing Committee on Agriculture and Agri-Food, Hearing (Ottawa: Canadian House of Commons, June 12, 2003).
130. Abergel and Barrett, pp. 142-143.
131. Peter Andree, "The biopolitics of genetically modified organisms in Canada," Journal of Canadian Studies, 2002, 37(3):162-191.
132. Standing Committee on Agriculture and Agri-Food, Evidence (Ottawa: Canadian House of Commons, May 12, 1998).
133. Peter Andree, "GM food regulation. An analysis of efforts to improve genetically modified food regulation in Canada," Science and Public Policy, 2006, 33(5):377-389. (Pubitemid 44210163)
134. Grace Skogstad, "Science and technology: Politicians and the public," in The Oxford Handbook of Canadian Politics, ed. John C. Courtney and David E. Smith (Oxford: Oxford University Press, 2010), pp. 699-726.
135. Grant, p. 199.
136. Canadian Biotechnology Advisory Committee, Improving the Regulation of Genetically Modified Foods and Other Novel Foods in Canada (Ottawa: Canadian Biotechnology Advisory Committee, 2002), http://dsp-psd. pwgsc.gc.ca/Collection/ C2-589-2001-1E.pdf (accessed October 21, 2009).
137. Grant E. Isaac and Jill E. Hobbs, "GM food regulations: Canadian debates," Canadian Journal of Policy Research, 2002, 3(2):105-113.
138. Andree, 2006.
139. Health Canada, Guidelines for the Safety Assessment of Novel Foods. Vol. 1. Preamble and Guidance Scheme for Notification (Ottawa: Food Directorate Health Protection Branch, 1994), http://www.hc-sc.gc.ca/ fn-an/alt-formats/hpfb- dgpsa/pdf/legislation/nvvli-eng.pdf (accessed November 1, 2009).
140. Health Canada, Approved Products (Ottawa: Food Directorate Health Protection Branch, 2010), http://www. hc-sc.gc.ca/fn-an/gmf-agm/appro/index-eng. php (accessed May 5, 2010).
141. Barbee, p. 70.
142. Health Canada, Information: Safety Assessment of the Flavr-Savr Tomato, http://www.hc-sc.ca/fn-an/gmf-agm/ appro/favr-savtm-tomato-tomate-flavr-savrmd- e.html (accessed September 14, 2006).
143. Health Canada, Information: Safety Assessment of the Flavr-Savr Tomato.
144. Andree, 2002, p. 177.
145. Einsiedel and Medlock, p. 153.
146. Pollara Research and Earnscliffe Research and Communications.
147. Einsiedel and Medlock, p. 153.
148. Decima Research.
149. Pollara Research, p. 4.
150. Pollara Research, p. 4.
151. Health Canada, 1994.
152. Canadian Biotechnology Strategy Secretariat, Canadian Biotechnology Strategy: An Ongoing Renewal Process (Ottawa: Canadian Biotechnology Strategy Secretariat, 1998), http://www.bioportal.gc.ca/ENGLISH/View. asp?pmiid5520&x5535 (accessed April 4, 2010).
153. Department of Foreign Affairs and International Trade, Biotechnology Transforming Society: Creating an Innovative Economy and aHigherQuality ofLife.ReportonBiotechnology 1998-2003 (Ottawa: Government of Canada, 2003).
154. Codex Alimentarius Commission, Report of the First Session of the Codex Ad Hoc Intergovernmental Task Force on Foods Derived from Biotechnology (Rome: World Health Organization and Food and Agriculture Organization of the United Nations, April 2000), ftp://ftp.fao.org/codex/ ALINORM01/Al01-34e.pdf (accessed May 1, 2010).
155. Peter Andree, 2006.
156. Grace Skogstad, Internationalization and Canadian Agriculture: Policy and Governing Paradigms (Toronto: University of Toronto Press, 2008), p. 230.
157. Pollara Research.
158. Decima Research.
159. Isaac, p. 211.
160. OECD, Recombinant DNA Safety Considerations. Safety Considerations for Industrial, Agricultural and Environmental Applications of Organisms Derived by Recombinant DNA Techniques (Paris: OECD, 1986), http:// www.oecd.org/dataoecd/ 43/34/40986855.pdf (accessed May 4, 2010).
161. Les Levidow, "Precautionary uncertainty: Regulating GM crops in Europe," Social Studies of Science, 2001, 31(6):842-874. (Pubitemid 33573700)
162. Ragnar E. Lö fstedt, Baruk Fischhoff, and Ilya Fischhoff, "Precautionary principles: General definitions and specific applications to genetically modified organisms," Journal of Policy Analysis and Management, 2002, 21(3):381-407. (Pubitemid 37239536)
163. Theofanis Christoforou, "The precautionary principle, risk assessment, and the comparative role of science in the European Community and the U.S. legal system," in Green Giants? Environmental Policies of the United States and the European Union, ed. Norman J. Vig and Michael G. Faure (Cambridge, MA: MIT Press, 2004), pp. 17-52.
164. Toke, p. 157.
165. Levidow, p. 849.
166. European Communities, "Council directive 90/219/ EEC of 23 April 1990 on the contained use of genetically modified micro-organisms," Official Journal of the European Communities, 1990, L117.
167. European Communities, "Council directive 90/220/ EEC of 23 April 1990 on the deliberate release into the environment of genetically modified organisms," Official Journal of the European Communities, 1990:L0015-0027.
168. European Commission, EU Policy on Biotechnology (Luxembourg: European Commission Environment DG, 2006), http://ec.europa.eu/environment/biotechnology/ pdf/ eu-policy-biotechnology.pdf (accessed March 24, 2010).
169. Mark A. Pollack and Gregory C. Shaffer, "Biotechnology: The next transatlantic trade war," Washington Quarterly, 2000, 23(4):41-54.
170. Dan R. Anderson, "Biotechnology risk management: The case of genetically modified organisms (GMOs)," CPCU Journal, 2000, 54:215-230.
171. Pew Initiative on Food and Biotechnology, U.S. vs. EU: An Examination of the Trade Issues Surrounding Genetically Modified Food (Pew Initiative on Food and Biotechnology, 2003), http://www.pewtrusts.org/our-work-report-detail. aspx?id=24138 (accessed May 1, 2010).
172. Toke, pp. 141-182.
173. Speech 02/314, David Byrne, European Commissioner for Health and Consumer Protection, to a Plenary Session of the European Parliament, Subject: GM Food and Feed (Strasbourg: European Parliament, July 2, 2002).
174. Speech 01/378, David Byrne, European Commissioner for Health and Consumer Protection, Subject: Proposal for a Regulation on GM Food and Feed (Brussels: European Parliament, September 11, 2001).
175. ClaireMarris, Brian Wynne, Peter Simmons, SueWeldon et al., Public Perceptions of Agricultural Biotechnology in Europe. Final Report of the PABE Research Project (Brussels: Commission of European Communities, 2001).
176. Toke, pp. 145-156.
177. Sylvie Bonny, "Why are most Europeans opposed to GMOs? Factors explaining rejection in France and Europe," Electronic Journal of Biotechnology, 2003, 6(1):52-71.
178. Michael W. Toffel and James E. Heyman, An Atlantic Divide? European and American Attitudes on Genetically Engineered Food. Working paper. (University of California, Berkeley: Haas School of Business, 2002).
179. McGarry, Wolf, and Domegan.
180. Annelies Verdurme et al., "Differences in public acceptance between generic and premium branded GM food products: An analytical model," in Market Development for Genetically Modified Foods, ed. Vittorio Santaniollo, Robert E. Evenson, and David Zilberman (New York: CABI Publishing, 2001), pp. 39-47.
181. Marris et al.
182. Claus-Hennig Hanf and Andreas Böker, "Is European consumerś refusal of GM food a serious obstacle or a transient fashion?" in Market Development for Genetically Modified Foods, ed.Vittorio Santaniollo, Robert E. Evenson, and David Zilberman (New York: CABI Publishing, 2001), pp. 49-54.
183. George Gaskell, Nick Allum, and Sally Stares, Europeans and Biotechnology in 2002: Eurobarometer 2002, http://ec.europa.eu/public-opinion/archives/ebs/ ebs-177-en. pdf (accessed September 3, 2009).
184. George Gaskell et al., Europeans and Biotechnology in 2005: Patterns and Trends, http://ec.europa.eu/research/ press/2006/pdf/pr1906-eb-64-3-final- report-may2006-en. pdf (accessed September 3, 2009).
185. Maria Lee, EU Regulation of GMOs. Law and Decision Making for a New Technology (Chelensham: Edward Elgar Publishing, 2008), pp. 2-4.
186. Andree, 2006, p. 4.
187. Bonny, p. 55.
188. Commission of the European Communities, White Paper on Food Safety (Brussels: Commission of the European Communities, 2000), http://ec.europa.eu/ dgs/health-consumer/ library/pub/pub06-en.pdf (accessed March 24, 2010).
189. Raymond ÓRourke, European Food Law, 3rd ed. (London: Sweet & Maxwell Ltd., 2005), pp. 193-198.
190. Commission of the European Communities, Communication from the Commission. Towards a Strategic Vision of Life Sciences and Biotechnology Consultation Document (Brussels: Commission of the European Communities, 2001), http://ec.europa.eu/biotechnology/docs/ doc-en.pdf (accessed March 24, 2010).
191. Douglas J. Stemke, "Genetically modified organisms: Biosafety and ethical issues," in The GMO Handbook. Genetically Modified Animals, Microbes and Plants in Biotechnology, ed. Sarah R. Parekh (Totowa: Humana Press, 2004), p. 108.
192. Colin A. Carter and Guillaume P. Gruère, "International approval and labeling regulations of genetically modified food in major trading countries," in Regulating Agricultural Biotechnology. Economic and Policy, ed. Richard E. Just, Julian M. Alston, and David Zilberman (New York: Springer Science + Business Media, 2006), p. 470.
193. European Union, Regulation (EC) No 182́9/2003 of the European Parliament and of the Council of 22 September 2003 on Genetically Modified Food and Feed (European Union: Official Journal of the European Union. Department of Health and Human Services, 2003): L268/5.
194. Gregory C. Shaffer and Mark A. Pollack, "The EU regulatory system of GMOs", in Uncertain Risks Regulated, ed. Michelle Everson and Ellen Vo (New York: Routledge- Cavendish, 2009), p. 280.
195. George T. Tzotzos, Graham P. Head, and Roger Hull, Genetically Modified Plants. Assessing Safety and Managing Risk (San Diego: Academic Press, 2009), pp. 138-143.
196. Commission of the European Communities, 2001.
197. European Commission, Report from the Commission to the European Parliament, the Council, and the European Economic and Social Committee. Life Sciences and Biotechnology-A Strategy for Europe. Second Progress Report and Future Orientations (Brussels: Commission of the European Communities, April 4, 2004), http://ec.europa.eu/ biotechnology/docs/com2004-250-en.pdf (accessed May 20, 2010).
198. European Commission, List of the Genetically Modified Material which has Benefited from a Favorable Risk Evaluation Within the Meaning of Article 47 of Regulation (EC) No 1829/2003 (Luxembourg: European Commission, 2006), http://ec.europa.eu/food/food/biotechnology/gmfood/ events-en.pdf (accessed May 20, 2010).
199. Luke Anderson, Genetic Engineering, Food, and Our Environment (White River Junction, VT: Chelsea Green Publishing, 2000).
200. McGarry, Wolf, and Domegan.
201. Hanf and Böker, p. 51.
202. Hans Peter Peters, John T. Lang, Magdalena Sawicka, and William K. Hallman, "Culture and technological innovation: Impact of institutional trust and appreciation of nature on attitudes towards food biotechnology in the USA and Germany," International Journal of Public Opinion Research, 2007, 19(2):191-220.